Continuative comprehensive investigations of the expression pattern of IFN-γ signaling components in MPN BMB and publicly available MPN data sets as well as human JAK2- and CALR-mutated cell lines revealed a more pronounced activation of this immune pathway in JAK2-mutated than in JAK2 wildtype MPN. The gene discussed is JAK2; the disease is myeloproliferative disorder.